NCT02723695

Brief Summary

The cochlear implant is an electrical hearing aid that restores the perception of surrounding sounds and speech intelligibility in profoundly deaf patients. During surgery, the labyrinthine break necessary for insertion into the cochlea of the implantable part may cause a malfunction of the vestibular system which can induce dizziness, balance and perception (of the gravitational vertical) disorders. Vestibular compensation and new sonic interactions could alter the balance control and the visual and postural spatial orientation perceptions. The usual treatment includes the monitoring of the patient's quality of life, of the vestibular function and of hearing. This study adds an assessment of spatial orientation and of posture.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 24, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

March 30, 2016

Status Verified

March 1, 2016

Enrollment Period

4 years

First QC Date

March 24, 2016

Last Update Submit

March 24, 2016

Conditions

Keywords

Cochlear implantPerceptionPostureQuality of life

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in postural perception of the gravitational vertical

    The same assessment will be performed 4 times (3 days before surgery, 3 days, 45 days, and one year after surgery). The measure is the average difference between the gravitational vertical and the tilt of the platform (in degree) over 20 trials.

    One year

Secondary Outcomes (7)

  • Change from baseline in visual perception of the gravitational vertical

    One year

  • Change from baseline in dynamic balance control

    One year

  • Change from baseline in quiet standing within a specific sound environment

    One year

  • Change from baseline in vestibular function

    One year

  • Change from baseline in speech recognition

    One year

  • +2 more secondary outcomes

Study Arms (2)

Patients

EXPERIMENTAL

Surgery (cochlear implantation)

Other: Evaluation of postural performances

Controls

ACTIVE COMPARATOR

Asymptomatic subjects

Other: Evaluation of postural performances

Interventions

Postural tests

ControlsPatients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Profound deaf patients who are scheduled for a cochlear implantation
  • Patients gave their written informed consent
  • Patients are affiliated to the french social welfare

You may not qualify if:

  • Disorders from the motor and/or somesthetic systems (especially the lower limbs)
  • Contraindications to the scheduled functional assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Nancy

Nancy, 54000, France

RECRUITING

MeSH Terms

Conditions

Deafness

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Cécile Parietti-Winkler, MD, PhD

    Central Hospital, Nancy, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cécile Parietti-Winkler, MD, PhD

CONTACT

Bettina Montaut-Verient, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
University Professor - Hospital Practitioner

Study Record Dates

First Submitted

March 24, 2016

First Posted

March 30, 2016

Study Start

March 1, 2014

Primary Completion

March 1, 2018

Study Completion

March 1, 2019

Last Updated

March 30, 2016

Record last verified: 2016-03

Locations